Genome-Wide association scan in HIV-1-infected individuals identifying variants influencing disease course

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  van Manen, Daniëlle ^a   Delaneau, Olivier ^b   Kootstra, Neeltje A ^a   Boeser Nunnink, Brigitte D ^a   Limou, Sophie ^b   Bol, Sebastiaan M ^a   Burger, Judith A ^a   Zwinderman, Aeilko H ^c   Moerland, Perry D ^c,d   van't Slot, Ruben ^e   Zagury, Jean François ^b   van't Wout, Angélique B ^a   Schuitemaker, Hanneke ^a  

^a SANQUIN RESEARCH   (Netherlands)

^b Bioinformatique et Chimie Moléculaire   (France)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d NETHERLANDS BIOINFORMATICS CENTRE   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CAUSE OF DEATH; DISEASE ASSOCIATION; DISEASE COURSE; FRANCE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEROCONVERSION; SINGLE NUCLEOTIDE POLYMORPHISM; COHORT ANALYSIS; FEMALE; GENETICS; HUMAN GENOME; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; NETHERLANDS; PHYSIOLOGY; SURVIVAL; VIROLOGY; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; POLYMORPHISM, SINGLE NUCLEOTIDE; SURVIVAL ANALYSIS; VIRAL LOAD; YOUNG ADULT;

EID: 79960643383     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022208     Document Type: Article

References (44)

1. Cascade, (2000) Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet 355: 1131-1137.
2. Veugelers PJ, Page KA, Tindall B, Schechter MT, Moss AR, et al. (1994) Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study. Am J Epidemiol 140: 747-758.
3. Klein MR, Miedema F, (1995) Long-term survivors of HIV-1 infection. Trends in Microbiology 3: 386-391.
4. Navis M, Schellens I, van Baarle D, Borghans J, van Swieten P, et al. (2007) Viral Replication Capacity as a Correlate of HLA B57/B5801-Associated Nonprogressive HIV-1 Infection. J Immunol 179: 3133-3143.
5. Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, et al. (2000) HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A 97: 2709-2714.
6. Gao X, Bashirova A, Iversen AK, Phair J, Goedert JJ, et al. (2005) AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med 11: 1290-1292.
7. Carrington M, O'Brien SJ, (2003) The influence of HLA genotype on AIDS. Annu Rev Med 54: 535-551.
8. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, et al. (1996) Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86: 367-377.
9. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, et al. (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273: 1856-1862.
10. Michael NL, Louie LG, Sheppard HW, (1997) CCR5-D32 gene deletion in HIV-1 infected patients. Lancet 350: 741-742.
11. De Roda Husman AM, Koot M, Cornelissen M, Brouwer M, Broersen SM, et al. (1997) Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann Intern Med 127: 882-890.
12. Ioannidis JP, Rosenberg PS, Goedert JJ, Ashton LJ, Benfield TL, et al. (2001) Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3′A alleles on HIV-1 disease progression: An international meta-analysis of individual- patient data. Ann Intern Med 135: 782-795.
13. O'Brien SJ, Nelson GW, (2004) Human genes that limit AIDS. Nat Genet 36: 565-574.
14. Fellay J, Ge D, Shianna KV, Colombo S, Ledergerber B, et al. (2009) Common genetic variation and the control of HIV-1 in humans. PLoS Genet 5: e1000791.
15. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, et al. (2007) A whole-genome association study of major determinants for host control of HIV-1. Science 317: 944-947.
16. van Manen D, Kootstra NA, Boeser-Nunnink B, Handulle MA, Van 't Wout AB, et al. (2009) Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection. AIDS 23: 19-28.
17. Catano G, Kulkarni H, He W, Marconi VC, Agan BK, et al. (2008) HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles. PLoS ONE 3: e3636.
18. Limou S, Le Clerc S, Coulonges C, Carpentier W, Dina C, et al. (2009) Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis 199: 419-426.
19. Dalmasso C, Carpentier W, Meyer L, Rouzioux C, Goujard C, et al. (2008) Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study. PLoS ONE 3: e3907.
20. Le Clerc S, Limou S, Coulonges C, Carpentier W, Dina C, et al. (2009) Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03). J Infect Dis 200: 1194-1201.
21. Herbeck JT, Gottlieb GS, Winkler CA, Nelson GW, An P, et al. (2010) Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. J Infect Dis 201: 618-626.
22. Pelak K, Goldstein DB, Walley NM, Fellay J, Ge D, et al. (2010) Host Determinants of HIV-1 Control in African Americans. J Infect Dis 201: 1141-1149.
23. Troyer JL, Nelson GW, Lautenberger JA, Chinn L, McIntosh C, et al. (2011) Genome-wide Association Study Implicates PARD3B-based AIDS Restriction. J Infect Dis 203: 1491-1502.
24. De Wolf F, Spijkerman I, Schellekens PThA, Langendam M, Kuiken CL, et al. (1997) AIDS prognosis based on HIV-1 RNA, CD4+ T cell count and function: Markers with reciprocal predictive value over time after seroconversion. AIDS 11: 1799-1806.
25. Mellors JW, Kingsley L, Rinaldo CR Jr, Todd J, Hoo BS, et al. (1995) Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 122: 573-579.
26. Rodriguez B, Sethi AK, Cheruvu VK, Mackay W, Bosch RJ, et al. (2006) Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 296: 1498-1506.
27. Mellors JW, Margolick JB, Phair JP, Rinaldo CR, Detels R, et al. (2007) Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 Cell count slope for progression to AIDS and death in untreated HIV-1 infection. JAMA 297: 2349-2350.
28. Spijkerman IJB, Prins M, Goudsmit J, Veugelers PJ, Coutinho RA, et al. (1997) Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men. AIDS 11: 1383-1388.
29. Steemers FJ, Gunderson KL, (2007) Whole genome genotyping technologies on the BeadArray platform. Biotechnol J 2: 41-49.
30. Centers for disease control (1993) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41 (RR-17): 1-19.
31. Loeuillet C, Deutsch S, Ciuffi A, Robyr D, Taffe P, et al. (2008) In vitro whole-genome analysis identifies a susceptibility locus for HIV-1. PLoS Biol 6: e32.
32. He JC, Husain M, Sunamoto M, D'Agati VD, Klotman ME, et al. (2004) Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. J Clin Invest 114: 643-651.
33. Kawashima Y, Pfafferott K, Frater J, Matthews P, Payne R, et al. (2009) Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458: 641-645.
34. Schellens IM, Navis M, van Deutekom HW, Boeser-Nunnink B, Berkhout B, et al. (2009) Adaptation of HIV-1 to the human immune system at the population level is driven by protective HLA-B alleles. Retrovirology 6: O41.
35. De Wolf F, Lange JMA, Houweling JTM, Coutinho RA, Schellekens PThA, et al. (1988) Numbers of CD4+ cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men. J Infect Dis 158: 615-622.
36. Van Griensven GJP, De Vroome EMM, Goudsmit J, Coutinho RA, (1989) Changes in sexual behaviour and the fall in incidence of HIV infection among homosexual men. Br Med J 298: 218-221.
37. Kwa D, van Rij RP, Boeser-Nunnink B, Vingerhoed J, Schuitemaker H, (2003) Association between an interleukin-4 promoter polymorphism and the acquisition of CXCR4 using human immunodeficiency virus type 1 variants. AIDS 17: 981-985.
38. Meyer L, Magierowska M, Hubert J-B, Theodorou I, Seroco cohort, et al. (1999) CC-chemokine receptor variants, SDF-1 polymorphism, and disease progression in 720 HIV-infected patients. AIDS 13: 624-626.
39. van Rij RP, De Roda Husman AM, Brouwer M, Goudsmit J, Coutinho RA, et al. (1998) Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants. J Infect Dis 178: 1806-1811.
40. van Rij RP, Broersen S, Goudsmit J, Coutinho RA, Schuitemaker H, (1998) The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection. AIDS 12: F85-F90.
41. van Haastrecht HJ, van Ameijden EJ, van den Hoek JA, Mientjes GH, Bax JS, et al. (1996) Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users. Am J Epidemiol 143: 380-391.
42. Geskus RB, (2000) On the inclusion of prevalent cases in HIV/AIDS natural history studies through a marker-based estimate of time since seroconversion. Stat Med 19: 1753-1769.
43. Ge D, Zhang K, Need AC, Martin O, Fellay J, et al. (2008) WGAViewer: software for genomic annotation of whole genome association studies. Genome Res 18: 640-643.
44. Aulchenko YS, Struchalin MV, van Duijn CM, (2010) ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics 11: 134.